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http://dx.doi.org/10.1016/j.stemcr.2016.09.009SUMMARYFollowing injury, adult skeletal muscle undergoes a well-coordinated sequence of molecular and physiological events to promote repair
and regeneration. However, a thorough understanding of the in vivo epigenomic and transcriptional mechanisms that control these
reparative events is lacking. To address this, we monitored the in vivo dynamics of three histone modifications and coding and non-
coding RNA expression throughout the regenerative process in a mouse model of traumatic muscle injury. We first illustrate how
both coding and noncoding RNAs in tissues and sorted satellite cells are modified and regulated during various stages after trauma.
Next, we use chromatin immunoprecipitation followed by sequencing to evaluate the chromatin state of cis-regulatory elements (pro-
moters and enhancers) and view how these elements evolve and influence various muscle repair and regeneration transcriptional
programs. These results provide a comprehensive view of the central factors that regulate muscle regeneration and underscore the mul-
tiple levels through which both transcriptional and epigenetic patterns are regulated to enact appropriate repair and regeneration.INTRODUCTION
Adult skeletal muscle is a postmitotic organ that coor-
dinates movement and constantly grows and adapts
by remodeling its structure and metabolism. After
insult or injury, adult skeletal muscle enables repair
and regeneration of existing fibers and formation of
new fibers through a population of stem cells that reside
underneath the basal lamina called satellite cells (SCs)
(Scharner and Zammit, 2011). The SCs reside in a special-
ized niche and change their quiescent complexion after
injury, whereby SCs activate, proliferate, differentiate
into myoblasts, and fuse to form myofibers (Bentzinger
et al., 2013; Kuang et al., 2008). Each step is affected
by various environmental signals and communication
with infiltrating and resident cells (Aurora and Olson,
2014; Burzyn et al., 2013; Heredia et al., 2013). Multiple
repair and regeneration subprocesses accomplished by
SCs (and other cell types) after muscle injury are orches-
trated by distinct epigenetic (Asp et al., 2011; Brancaccio
and Palacios, 2015), transcriptional (Braun and Gautel,
2011; Buckingham and Rigby, 2014) and post-tran-
scriptional events. However, the integrative dynamicsStem Cell Rep
This is an open access article under the Cof transcriptional networks and regulatory epigenetic
switches at genome-wide levels have only been partly
characterized in vivo (Liu et al., 2013; Giordani and
Puri, 2013) and, as such, our understanding of the mo-
lecular processes involved in muscle regeneration have
been limited.
Herein, the in vivo evolution of coding and noncoding
expression and three different chromatin modifications
(H3K4me3, H3K4me1, and H3K27ac) were profiled across
nine time points (t = 3 hr to 672 hr) from an injured and
uninjured contralateral tibialis anterior (TA) muscle. The
generated genomic maps were then contrasted against
myogenic transcription factors (MyoD and MyoG)
genomic binding data (Cao et al., 2010; The Mouse
ENCODE Consortium, 2014) to determine shared and dis-
tinguishing signatures at cis-regulatory elements during
different stages after injury. The dynamic levels of
numerous coding and noncoding transcripts, chromatin
state transitions, and differential binding at transcription
factor (TF) motifs were integrated and assessed to construct
a comprehensive view of the key transcriptional and chro-
matin factors that influence and modulate in vivo muscle
repair and regeneration dynamics.orts j Vol. 7 j 983–997 j November 8, 2016 j ª 2016 The Author(s). 983
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Experimental Overview for
Profiling Molecular Mechanisms Gov-
erning In Vivo Tibialis Anterior Muscle
Regeneration after Severe Trauma
(A) Schematic diagram of injury model and
process flow for chromatin and transcript
extraction. A representative example of the
Mef2a gene at 3 hr post injury is shown
where the promoter (labeled P in gray) and
enhancer regions (labeled E1 and E2 in
purple) are depicted.
(B) (Top) Line plots of hierarchically clus-
tered RNA-seq data through time revealed
clusters up- and downregulated at different
time periods that were associated with
different stages of muscle repair and
regeneration. (Bottom) Bar graphs of gene
expression values of six different genes
corresponding to different stages of the
muscle regeneration process through time
from left to right. Error bars represent 1 SD.RESULTS
Severe Muscle Trauma Induces Extensive
Transcriptional andPost-transcriptional Regulation in
Both Coding and Noncoding Transcripts
To gain insights into the healing process after adminis-
tration of trauma, we performed expression profiling by
RNA sequencing (RNA-seq) and small RNA-seq (miRNA-
seq) (Aguilar et al., 2015) for both the injured and contralat-
eral tissues for multiple time points (Figure 1), and lumped
the datasets into three key stages (early, 3–24 hr; middle,
48–168 hr; late, 336–672 hr). Hierarchical clustering of
the RNA-seq data through time revealed clusters up- and
downregulated that were associated with different stages
of muscle repair and regeneration (Figure 1B). For example,
chemokine ligands 2 and 7 (Ccl2 and Ccl7), which are
important for the recruitment of various immune cells to
the injuredmuscle, peaked in expression in the early period
(at 24 hr after injury). Annexins 1 and 2 (Anxa1 andAnxa2),
cellular membrane binding proteins that are important
for promoting migration of SCs, demonstrated a different
expression profile and peaked in the middle period
(48–72 hr). Laminin subunits b-1 and a-4 (Lamb1 and
Lama4), which are cellular adhesion molecules present in
the basement membrane, exhibited a peak in differential
expression in the late period (336 hr). Pathway analysis
of the time-clustered RNA-seq data showed an initial burst
of proinflammatory and immune-response transcripts in
the early period, followed by activation, proliferation,984 Stem Cell Reports j Vol. 7 j 983–997 j November 8, 2016and differentiation of myogenic precursors and extracel-
lular matrix (ECM) remodeling in the middle and late
time periods, which was consistent with previous studies
of muscle tissue injury and in line with a productive heal-
ing process (Tidball, 2005; Warren et al., 2007).
Regulation of muscle regeneration has also recently been
shown to occur post-transcriptionally, where microRNAs
(miRNAs) bind to the 30 UTR of mRNAs and inhibit transla-
tion (Chen et al., 2005; Kim et al., 2006). Small RNA-seq
was performed at multiple time points from each stage
and 841 miRNAs were detected. Of these, 143 miRNAs
showed dynamic behavior and reinforced many of the re-
sults observed from the RNA-seq datasets, where early upre-
gulated miRNAs were associated with inflammation and
immune system programs andmiddle- and late-stage upre-
gulated miRNAs were associated with muscle repair and
regeneration (Figure S1). For example, in the early period
the inflammatory miR-223 was upregulated whereas its
expression subsided in the middle and late periods. In
the middle period, miR126b (associated with angiogenic
and chemokine signaling, Zhang et al., 2013), the miR-29
family (regulator of fibrosis and collagen expression),
miR-21 (regulator of phosphatidylinositol 3-kinase [PI3K]/
Akt signaling), and miR-31 and miR-206 (differentiating
myoblasts) were upregulated, which was consistent with
pathways observed to promote myogenic differentiation
during the middle period (Cacchiarelli et al., 2010, 2011).
To gain insights into the consequences of differential
expression of these dynamic miRNAs, we assessed pairwise
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Figure 2. Dynamics of Noncoding RNAs
after Severe Muscle Trauma
(A) Cross-correlation analysis of dynamic
miRNAs and their mRNA targets. The heatmap
is plotted as the Pearson correlation coeffi-
cient of the expression of 35 dynamic miRNAs
(x axis) against the expression of their 200
predicted mRNA targets (y axis). A positive
correlation coefficient is labeled in yellow
and a negative correlation coefficient in
blue.
(B) Expression heatmap of 124 lncRNAs
through time from left to right. Heatmap is
depicted as fold change of injured versus
uninjured.correlations in expression patternswith their 30 UTRmRNA
targets. We observed multiple miRNA-mRNA targets that
were reciprocally regulated during the time course, and
hierarchical clustering of the correlations revealed three
clusters (Figure 2A). The first cluster contained positively
correlatedmiRNA-mRNA targets that were significantly up-
regulated in the early period (miR-709, miR-6538, miR-378
family with genes Atf3, Stat5b, Fas, and Btg2) and could be
ascribed to functional classes related to immune regulation
and DNA-damage cellular response. The second cluster
was upregulated in the middle and late periods and was
associated with myogenic growth and development. For
example, we detected upregulation of miR-206, miR-205,
miR-203, miR-1a, miR182, and miR-31 along with several
target genes (Igf2, Igfbp5) that were previously identified
as critical regulators of SC differentiation (Liu et al.,
2012). The third cluster possessed the largest number of
positively correlated miRNA-mRNA targets and was also
upregulated in the middle period. This cluster was linked
to transforming growth factor b (TGF-b) signaling andECM and cytoskeletal remodeling, and contained miR-
18a, miR-21, miR-335, miR34c, and miR-142 along with
target genes Tgfbi, Anxa1, Sdcbp, Cav1, and Timp2.
Long noncoding RNAs (lncRNAs) are a new class of
transcripts that have recently been discovered and play
diverse regulatory roles inmuscle differentiation anddisease
(Neguembor et al., 2014; Cesana et al., 2011; Gong et al.,
2015). Previously identified lncRNAs were intersected with
the RNA-seq datasets and 2,444 lncRNAs were detected,
with 124 lncRNAs exhibiting dynamic behavior. Figure 2B
shows the differentially expressed lncRNAs clustered into
three groups, and similar to themRNA andmiRNA datasets,
weviewupregulated lncRNAs involved in inflammatory and
immune-related processes (Csf1r, Il1bos, Ly9, Treml1, CD68,
and Ncf1) in the early time points followed by increases in
expressionof lncRNAs thatwerepreviously shown tobe crit-
ical for myogenic differentiation (H19 and linc-MD1) in the
middle and late periods (Dey et al., 2014). Uniquely, in the
early period we also detected upregulated lncRNAs that
were found in other injured muscle tissues (myocardialStem Cell Reports j Vol. 7 j 983–997 j November 8, 2016 985
AB
C
D
Figure 3. Temporal Coding and Noncoding Transcriptional Signatures of Sorted Satellite Cells Post Trauma Highlights Regenerative
Transitions
(A) Representative isolation plot of FACS of satellite cells for Sca-1, CD45, Mac-1, Ter-119, b1-integrin+, and Cxcr4+. Purple gates
indicate subpopulations containing satellite cells and numbers specify percentage of cells within gate.
(B) (I) Expression heatmap of 994 representative differentially expressed genes through time where yellow is low expression and red is
high expression. (II) Dendrogram showing global hierarchical clustering of RNA-seq datasets separated by their Jensen-Shannon distance.
(III) Venn diagram of unique and overlapping differentially expressed genes for the time points sampled. (IV) Left: bar graphs of false
discovery rates for over-represented GO pathways derived from hierarchical clustering. Blue bars are upregulated GO terms and red bars are
downregulated GO terms. Right: bar plots of RNA expression profiles of representative genes from each cluster are plotted to the right of
each cluster through time from left to right. FPKM, fragments per kilobase of transcript per million mapped reads.
(C) Bar graphs of individual gene expression values through time from left to right.
(D) Expression heatmap of 107 differentially expressed miRNAs observed where white is low expression and green is high expression.infarction-associated transcriptsMirt1andMirt2), suggesting
a common regulatory scheme (Zangrado et al., 2014).
Temporal Transcriptional Signatures of Satellite Cells
Reflect a Dynamically Changing Tissue Composition
SCs from injured tissues were isolated using flow cytometry
(Sca-1, CD45, Mac-1, Ter-119, b1-integrin+, Cxcr4+;986 Stem Cell Reports j Vol. 7 j 983–997 j November 8, 2016Figure 3A) at time points associated with activation, prolif-
eration, and differentiation (3, 24, 48, 72, and 168 hr), and
RNA-seq and miRNA-seq was performed. A total of 17,636
mRNAs were detected and 9,953 genes were differentially
expressed at one or more time points (Figure 3B). Of the
time points sampled, 168 hr possessed the highest number
of genes that were differentially expressed (584) compared
with 434 genes for 3 hr, 108 for 24 hr, 405 for 48 hr, and 241
for 72 hr. These datasets were compared with previously
published microarray datasets (Liu et al., 2013; Pallafac-
china et al., 2010; Farina et al., 2012) of isolated SCs and
excellent agreement was observed. Hierarchical clustering
of the datasets through time revealed five clusters, and
gene ontology (GO) analysis of the differentially expressed
genes within each cluster illustrated significant pathway
perturbations (Figure 3B). A set of genes that remained
highly expressed over the time course were in the first
cluster and were associated with ATP synthesis, ion chan-
nel activity, and regulation of glucose and insulin. The
second and third clusters were low in expression from 3
to 48 hr and upregulated from 72 to 168 hr (Figure 3C)
and contained multiple genes associated with myogenic
differentiation (MyoD1, MyoG, Des, Ash2l, Hes6), cell-cycle
regulation (Ccna2, Ccnb1, Dnmt1, Birc5), cytoskeletal
proteins (Cdh15, Tmem8c/Myomaker), and mitochondrial
metabolism. The fourth and fifth cluster displayed a
relatively high level of expression from 3 to 48 hr that
decreased from 72 to 168 hr and were associated with
development, and contained markers of quiescent SCs
(Pax7, Foxo3; Figure 3C).
miRNA-seq was performed on the fluorescence-activated
cell sorting (FACS)-sorted SCs, and 341 miRNAs were de-
tected for at least one time point (Figure 3D). Of these,
107 miRNAs were differentially expressed (Figure S1) and
many of the dynamic miRNAs mirrored expression pat-
terns observed fromwhole tissues. For example, in the early
period miR-22 was downregulated in both SCs and at the
tissue level. miR-22 has recently been shown (Lu et al.,
2015) to inhibit Hdac4 expression, which is a well-known
negative regulator of myogenesis. During this time period,
the miR-181 family (modulators of PI3K signaling and
metabolic adaption needed for subsequent proliferation)
and miR-191 (promotes cell migration via induction of
Tgf-b signaling) also showed decreases in expression, which
is consistent with transcriptional changes in metabolism,
Tgf-b-signaling, and PI3K signaling observed in the tissue
at that time. In the middle time periods (R72 hr), changes
in expression of let-7c (SMAD and Tgf-b signaling inhibi-
tor),miR-16 (regulator of proliferation and cell-cycle genes,
Liu et al., 2008), miR-148a (modulates fate commitment),
miR-182 (repressor of negative regulators of cell-cycle
genes), and several other members of the let-7 family (asso-
ciated with cell cycling and self-renewal) were detected
compared with low expression in the earlier time points
(3–48 hr). miR-486a and miR-486b were also upregulated
at these time points, and were previously shown to poten-
tiate proliferation by targeting p85a, Igf1r, and Igf1, which
is consistent with a decrease in expression of these genes
at the same time points (72 and 168 hr). Multiple other
miRNAs exhibited similar expression profiles (low expres-sion from 3 to 48 hr and high expression from >72 hr)
such as 21a, 125a, 127, 199a, 206, 411, and 541, consistent
with previous findings for isolated SCs (Arnold et al., 2011).
Acute Muscle Trauma Stimulates Genome-wide
Chromatin Remodeling
To further probe the regulation of the coding and non-
coding transcriptional programs, we used chromatin
immunoprecipitation followed by sequencing (ChIP-seq)
to globally map the chromatin state of various cis-regula-
tory elements at nine time points. Validated antibodies
for histone H3 lysine 4 trimethylation (H3K4me3), a modi-
fication associated with promoters, and H3K4me1 and
H3K27ac, associated with poised and active enhancer re-
gions (Ernst et al., 2011), respectively, were used to enrich
chromatin. Each tissue from each time point was immuno-
precipitated using the three antibodies, and ChIP-seqmaps
from the same antibody and time point were merged, re-
sulting in 54 chromatin state maps covering >1.5 billion
reads.
In the early time period 93,149 sites were enriched for
H3K4me3 and 104,890 sites for the middle period, fol-
lowed by 141,948 sites for the late period (Figure 4).
Of these, 1,606 were differentially enriched in the early
time points relative to the controls, 6,733 in the middle
time points, and 6,121 in the late time points. To integrate
sites that gained or lost the H3K4me3 modification during
the time course with transcriptional activity (fragments
per kilobase of transcript per million mapped reads
[FPKM] > 1), we merged RNA-seq results with H3K4me3
enrichments. Approximately 58% of sites were found to
associate with transcriptional activity (FPKM > 1) and
4,241 sites exhibited dynamics (acquisition or loss of the
histone modification) through at least one stage (early to
middle, middle to late, early to late).
In contrast to H3K4me3, which has previously been
shown to be largely static during chromatin remodeling
events (Garber et al., 2012), H3K4me1 andH3K27ac, which
demarcate enhancer elements, were observed to be highly
dynamic (Rada-Iglesias et al., 2011). H3K4me1 resides on
both poised and active enhancers, whereas H3K27acmarks
active sites (Creyghton et al., 2010). In the early time period
93,938 sites enriched for H3K4me1 were identified, fol-
lowed by 106,353 sites for the middle period and 28,663
sites for the late period. H3K27ac showed similar behavior
with 32,285 sites enriched in the early time period, 43,780
sites in the middle period, and 13,748 sites in the late
period. The highest number of sites that acquired
H3K27ac was found in the 72-hr period (28,178 sites)
compared with 11,535 for the 48-hr stage and 4,067 for
the 168-hr stage (Figure 4). In contrast to H3K4me3 en-
richments, which were primarily found at or near tran-
scriptional start sites, the enhancer marks H3K4me1 andStem Cell Reports j Vol. 7 j 983–997 j November 8, 2016 987
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Figure 4. Distribution of Enriched Chro-
matin Sites across the Genome during
In Vivo Muscle Regeneration
(A) Total and differential number of en-
riched sites for H3K4me3 and H3K27ac.
(B) Distribution of peaks across various
genomic elements (promoter, intergenic,
intron, near-gene: ± 2 kbp from transcrip-
tional start site, exon).
(C) Shared and unique numbers of enriched
chromatin sites corresponding to different
genomic elements in (B).H3K27ac were more broadly distributed across inter- and
intragenic loci (Figure 4). Since H3K4me1 demarcates
both poised and active enhancers and H3K27ac marks
only active enhancers (Ostuni et al., 2013), the total num-
ber of enhancer elements (identified by H3K4me1+,
H3K27ac+, and H3K4me3) was determined, and the
ratio of the enriched enhancers was quantified as active
(H3K4me1+ and H3K27ac+) or poised (H3K4me1+ and
H3K27ac). A wide spectrum of binding patterns was
observed for the two enhancer categories across the nine
time points, with the majority of differential active en-
hancers occurring at intragenic and intergenic loci for all
time periods. The highest number of differential active
enhancers (injured+ and control) was found for the mid-
dle period, with the largest number of active enhancers
occurring in the 72-hr period.
Integrative Analysis of Enriched Enhancers Highlights
Transient Recruitment of Different Types of Immune
Cells after Muscle Trauma
GO term analysis of the enriched differential enhancer
peaks for the early period demonstrated over-represented
terms, similar to the transcriptional groups (immune
response, chemokine and cytokine signaling, inflamma-988 Stem Cell Reports j Vol. 7 j 983–997 j November 8, 2016tion, andmetabolism of lipids and lipoproteins; Figure 5A).
The result of these chromatin and transcriptional enrich-
ments in the early period is consistent with upregulation
of cytokines and chemokines (Il-6 andTNFa), and increases
in expression of pleiotropic transcription factors such as
components of the activator protein 1 (AP-1) complex
(c-Fos, Atf3, JunB), STATs, NF-kb, EGR, and PU.1 (Figures
5B and S2), which stimulate a permissive chromatin state
and have previously been shown to induce SC activation
genes such as Myod1, Myf6, and c-Myc (Toth et al., 2011).
In the middle time period (48–168 hr after injury),
multiple genes associated with Tgf-b signaling were differ-
entially expressed, such as several Smads (Figure S3), which
have been shown to interact with chromatin remodeling
complexes such as histone acetyltransferases p300 and
CBP (CREB-binding protein) to induce H3K27 acetyla-
tion (Mullen et al., 2011). Consistent with this view, we
observed the highest number of sites that acquired
H3K27ac in the middle time period (Figure 4). GO annota-
tion of the differential enhancer peaks for the middle
period revealed multiple enrichments for anti-inflamma-
tory cytokines, G-protein-coupled receptors, and the Rho
family of small GTPases (Figures 5 and S4). This result is
in agreement with the peak in expression of SRF target
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Figure 5. Chromatin Landscapes Are Immediately Modified after Severe Muscle Trauma and Reflect Recruitment of Different Types
of Immune Cells
(A) Heatmap of p values for over-represented pathways derived from enriched H3K27ac peaks in the early time period (3–48 hr). AP-1,
activator protein 1; CXCR2, C-X-C motif chemokine receptor 2; FC gamma R, Fc-g receptor; GM-CSF, granulocyte macrophage colony-
stimulating factor; HIF-1a, hypoxia-inducible factor 1a; IL8, interleukin-8; NF-kb, nuclear factor kB; TNF, tumor necrosis factor.
(B) Bar graphs of individual gene expression values through time from left to right of immune-cell related transcripts upregulated in the
early period (injured samples are colored and uninjured samples are uncolored). Error bars represent 1 SD.
(C) Normalized ChIP-seq tracks of H3K4me1, H3K27ac, and H3K4me3 profiles around the Atf3 gene. Enriched enhancer regions are
highlighted in gray.
(D) Heatmap of over-represented pathways derived from enriched H3K27ac peaks in the middle time period (48–336 hr). GPCR, G-protein-
coupled receptor; IL-4, interleukin-4; MMP, matrix metalloprotein.
(E) Histograms of individual gene expression values through time from left to right of anti-inflammatory related transcripts. Interleukin-4
receptor a (Il4ra), interleukin-10 receptor a (Il10ra), and interleukin-13 receptor a 1 (Il13ra1), colony-stimulating factor 1 receptor
(Csf1r), and peroxisome proliferator-activated receptor g (Pparg). Error bars represent 1 SD.
(F) Normalized ChIP-seq tracks of H3K4me1, H3K27ac, and H3K4me3 profiles around the Ppar-g gene. Enriched enhancer regions are
highlighted in gray.genes (Kuwahara et al., 2005) and anti-inflammatory cyto-
kines interleukin-4, -10, and -13 (Il-4, Il-10, Il-13), which
induceM2macrophage polarization and are essential com-
ponents for resolution of inflammation and tissue repair
(Figure 5). Increases in expression of these factors werealso mirrored by upregulation of the macrophage-derived
matrix metalloproteinase 12 (Mmp12), which cleaves and
inactivates CXC chemokines (Cxcl1, -2, -3, -5, and -8) and
monocyte chemotactic proteins (Ccl2, -7, -8, and -13), in-
hibiting leukocyte flux to the injured site and abrogatingStem Cell Reports j Vol. 7 j 983–997 j November 8, 2016 989
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Figure 6. Chromatin State Transitions
Associated with Activation of Basement
Membrane Repair and Myogenic Regen-
eration
(A) Normalized ChIP-seq tracks of H3K4me1,
H3K27ac, and H3K4me3 profiles around the
myoferlin (MyoF) gene. Enriched enhancer
regions are highlighted in gray and corre-
sponding enriched TF motif is labeled.
(B) Line graphs of individual gene expres-
sion values of MyoF and associated tran-
scription factor (Tgif1) through time from
left to right (injured samples are colored red
and uninjured samples are colored blue).
Error bars represent 1 SD.
(C) Normalized ChIP-seq tracks of H3K4me1,
H3K27ac, and H3K4me3 profiles for a subset
of myogenesis genes. The black box outlines
the H3K27ac region, which is expanded in
(D) and illustrates the Mef2a locus.
(D) Normalized H3K27ac ChIP-seq track
highlighting enriched enhancers around the
Mef2a gene. The enriched enhancer regions
are highlighted in gray and corresponding
enriched TF motif (MyoD) is labeled beneath
the track.
(E) Bar graph of expression for MyoD. Error
bars represent SEM.the amount of proinflammatory molecules present in the
injured tissue (Figure S5).
Chromatin State Transitions Associated with
Activation of ECM Repair andMyogenic Regeneration
A primary determinant of successful muscle regeneration
after injury is ECM remodeling (Calve et al., 2010), which
provides a scaffold for proliferating SCs to migrate, differ-
entiate, and fuse in the correct orientation. In the middle
period, increases in expression and multiple enhancer
enrichments were viewed for genes associated with ECM
remodeling, such as components of the basement mem-
brane (myoferlin, laminin, collagen VI genes, annexins
Figures 6 and S5), glycoproteins, and Mmps. In addition,
during the middle period chromatin remodeling and upre-
gulation of genes associated withmuscle development and
architecture were also detected (Figure 6).
To understand this critical step further, we conducted
additional analysis of the differential active enhancer sites
during the middle period by evaluating the number of en-
riched active enhancers that overlapped with MyoD and
MyoGChIP-seq data (Cao et al., 2010; TheMouse ENCODE
Consortium, 2014; Mousavi et al., 2013). The largest in-
crease inMyoD binding sites at active enhancers was found990 Stem Cell Reports j Vol. 7 j 983–997 j November 8, 2016at 72 hr (Figure S6), which is consistent with the largest in-
crease in expression (Figure 6E) and known association be-
tweenMyoD and p300/CBP on E-boxmotifs of target genes
during myogenic differentiation (Palacios and Puri, 2006).
The greatest increase in MyoG binding sites at active en-
hancers was viewed at 336 hr, which agrees well with
observation of late myogenic differentiation programs in
that time period. Compiling the enriched enhancer sites
coincident for MyoD or MyoG binding and performing
GREAT (genomic regions enhancement of annotations
tool) analysis revealed over-represented terms nominally
associated with myogenic differentiation such as different
types of growth factor signaling (insulin growth factor
[Igf], fibroblast growth factor [Fgf], hedgehog), p38
mitogen-activated protein kinase (p38-MAPK), and PI3K
signaling (Figure S6 and discussed further below).
Chromatin Regulation of PI3K Pathway Reflects
Transition from Myoblast Proliferation and
Differentiation
IGF signaling plays a crucial role in muscle repair and
regeneration after injury, most notably during the transi-
tion between myoblast proliferation and differentiation
whereby Igf2 activates the Akt pathway and targets bound
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Figure 7. PI3K/Akt Activation Promotes
Transition from Proliferation toward
Myogenic Differentiation
(A) Bar graphs of individual gene expression
values for various components of the PI3K
and AKT pathways through time from left to
right. Error bars represent SEM.
(B) Normalized ChIP-seq tracks of H3K27ac
profiles showing differential enhancer ac-
tivity of the PI3Kr1, PI3Kr5, and PI3Kr6
loci. Enriched enhancer regions are high-
lighted in gray and corresponding enriched
TF motifs are labeled underneath.by MyoD. In line with this observation, an increase in
expression of Igf1 was detected in the early period (Pelosi
et al., 2007), which subsided in the middle period when
several Igfbps and Igf2 and members of the Akt pathway
were observed to be upregulated along with miR-483
(which is embedded in the second intron of Igf2 and is
an SRF target) (Figure 7A; Schiaffino and Mammucari,
2011). One component of the IGF pathway, the PI3K
component, is essential for skeletal muscle regeneration
and is composed of three primary classes (classes I, II, III)
that are structurally and functionally distinct. The three
class IA PI3K p110 catalytic subunits (a, b, and d) are ex-
pressed in skeletal muscle (Matheny and Adamo, 2010)
and of these subunits, p110a and p110b have been shown
to positively influence myoblast proliferation and differ-
entiation (Matheny et al., 2012, 2015). In the early and
middle periods following injury, we observed differential
enhancer binding and increases in expression of PI3K cata-
lytic subunits p110a (Pik3ca), p110b (Pik3cb), and p110d
(Pik3cd) as well as the PI3K p85a (Pik3r1) regulatory subunit
for the injured muscle compared with the contralateral
control (Figure 6A). Increases in expression and active en-
hancers were also viewed for class IB p110g (Pik3cg) and
its regulatory subunit p101 (Pik3r5) during the healing
process, which are expressed abundantly in immune cells.
TF binding analysis of the enriched enhancer regions for
the regulatory subunit p85a showedmotifs for signalmedi-
ators of Il-4 and the anti-inflammatory response, which is
consistent with activation of pathways during this time
period (Figure 7B).
The temporal increases in PI3K expression (and other
positive myogenic regulatory pathways) between 24 and72 hr post injury were also concomitant with increases in
expression of negative feedback regulators such as Mg53
(disruptor of upstream IGF signaling via ubiquitin ligases,
Yi et al., 2013), Xbp1 (Acosta-Alvear et al., 2007), and
Usf1 (which compete with or co-occupy binding sites for
MyoD and Mef2), and Id1, Id2, and Snai1 (which reduce
the binding affinity of MyoD and Mef2; Soleimani et al.,
2012). The negative regulators began to decrease in expres-
sion starting at 72 hr (Figure S7), further reinforcing the
observation of myogenic differentiation at this time.DISCUSSION
Muscle recovery after traumatic injuries such as an occu-
pational crush or blast suffered during military combat
canonically induces a predisposition for additional injuries
and chronic pain owing to incomplete regeneration of the
tissue. Our understanding of how different factors translate
to influence the chromatin architecture that regulatesmus-
cle regeneration has been limited. Herein, we used integra-
tive genomic mapping technologies to profile coding and
noncoding expression and the in vivo chromatin state of
various cis-regulatory elements, and found successive
waves of transcriptional and chromatin changes during
the course of healing. To obtain broad, unbiased views of
the diverse repair and regeneration pathways utilized by
different cell types after trauma, we performed profiling
of both whole, unfractionated muscle tissue and FACS-
sorted SCs (Liu et al., 2015).Whole-tissue profiling enabled
capture of signals emanating from multiple cell types and
the capacity to profile multiple chromatin modificationsStem Cell Reports j Vol. 7 j 983–997 j November 8, 2016 991
from a single tissue without pooling tissues from multiple
animals. The contralateral/uninjured tissue was used as
the control for this study; however, recently (Rodgers
et al., 2014) it was shown that systemic signals induced
from acute trauma stimulate SCs within the contralateral
muscle to undergo a transition to an alert state that primes
their differentiation potential. Thus, while we normalized
changes to the contralateral tissue, the normalization
may not be reflective of an unperturbed muscle.
Pathway analysis of the time-clustered whole-tissue
RNA-seq data revealed waves of transcription associated
with proinflammatory and immune responses in the early
period, followed by transcriptional signatures associated
with myogenic differentiation and ECM remodeling in
the middle and late time periods. Disruption of the mus-
cle integrity by acute trauma also produced noncoding
RNA (ncRNA) dynamics very similar to those observed
in other muscle myopathies (Neguembor et al., 2014; Ce-
sana et al., 2011; Eisenberg et al., 2007), suggesting the
modulation of common molecular pathways. miRanda-
mirSVR (Betel et al., 2010) was used to study the interac-
tion of dynamic miRNA-mRNA pairs and whether their
expression patterns changed concomitantly with time.
We identified 200 miRNA-mRNA mutually dynamic rela-
tionships and clustered the pairs into three categories of
immune regulation, TGF-b signaling, and ECM and cyto-
skeletal remodeling followed by myogenic differentiation.
These three clusters highlight a temporal regulatory pro-
gram whereby infiltrating immune cells release signaling
molecules that trigger SC activation, followed by a transi-
tion whereby the activated progenitors proliferate and
are repressed from differentiating by TGF-b signaling
and changes to the surrounding matrix. These repressive
cues were extended via other regulatory mechanisms
(see below) and began to subside at 72 hr when a new
class of ncRNAs (miR-206, miR-205, miR-203, miR-1a,
miR182, miR-31, H19, and linc-MD1) increased in expres-
sion. Similar to the mRNA and miRNA-seq results, three
clusters of differentially expressed lncRNAs were detected.
Interestingly, H19 (which was upregulated in the middle
and late periods) and another lncRNA called lncMyoD
(which was upregulated in the early and middle periods)
bind mRNA IGF2 binding proteins, suggesting that induc-
tion and stabilization of this pathway may be regulated
temporally via different combinations of lncRNAs. Since
muscle repair and regeneration utilizes many feedforward
and feedback loops, tightly regulated expression patterns
across multiple levels may facilitate a precise way to pre-
vent extrinsic signal propagation from adjacent tissues
that are also regenerating or responding to the injury,
reinforce or tune noisy expression patterns, and perhaps
facilitate a metabolically efficient mechanism to quickly
respond after injury.992 Stem Cell Reports j Vol. 7 j 983–997 j November 8, 2016RNA-seq of SCs reinforced transcriptional dynamics
observed from whole tissues, whereby in the early period,
immune-response and chemokine transcripts were upregu-
lated, followed by proliferation and differentiation during
the middle time period. Several TFs associated with quies-
cent cells (Pax3, Pax7, Foxo3, Spry1) and immune response
(c-Jun, c-Fos, Atf3, Egr1) exhibited downregulation at the
same time that genes associated with cell-cycle progression
(Ccna2, Ccnb1, Dnmt1, Birc5), differentiation, and fusion
(MyoG, Hes6, Tmem8c, Cdh15) were upregulated (>72 hr).
During the same time period, we also observed a switch
from high to low expression of lysine demethylase 6A
(Kdm6a or Utx), which regulates removal of the repressive
H3K27me3chromatin mark (Faralli et al., 2016), to low to
high expression of a component of a histone methyltrans-
ferase complex (Ash2l). Ash2l is part of the Trithorax com-
plex that specifically methylates the fourth lysine residue
of histone H3 (H3K4) and is targeted by Pax7 to activate
Myf5 target genes (Almada and Wagers, 2016). Combining
these dynamics suggests that in the early time period,
upregulated TFs and chromatin remodelers help to estab-
lish a more accessible chromatin state at myogenic loci,
which is consistent with the increase in enrichments of
H3K4me3, H3K4me1, and H3K27ac. Moving into the
middle period, as stress-responsive and other immune-acti-
vated transcripts decrease in expression, another set of
TFs and chromatin remodelers is then upregulated and
titrated via miRNAs (see below) to enact appropriate satel-
lite cell proliferation and differentiation. miRNA-seq on
the FACS-sorted SCs demonstrated that the programs of
activation, proliferation, and subsequent differentiation
are tightly controlled. For the time points linked with acti-
vation and mobilization (3–48 hr), several miRNAs were
downregulated, such as miR-22, which is activated by the
transcription factors AP-1 andNF-kB. SincemiR-22 inhibits
expression of Hdac4 and targets c-myc, which also sup-
presses MyoD-initiated myogenic differentiation and pro-
motes proliferation, a regulatory program can be inferred
whereby stimuli from infiltrating immune cells induce acti-
vation of TFs that promote the progenitors to activate,
mobilize, and begin to proliferate but are repressed from
differentiating. Other post-transcriptional factors such as
miR-181, miR-191, and miR-222 appear to reinforce this
program in the early time periods and as inflammation
and immune-stimulated signatures drop in expression,
another program begins around 72 hr via increases of
expression of regulators of cell-cycle genes (miR-16, miR-
182, miR-486) and myogenic differentiation (let-7 family,
miR-206).
The efficacy of myogenic transcription factors to initiate
and maintain muscle gene expression programs depends
critically on the chromatin state (Blais et al., 2005; Blum
et al., 2012) of their targets as well as their interactions
with each other (Liu et al., 2014; Molkentin et al., 1995)
and other TFs. Quantifying the genome-wide changes in
histone modifications revealed that a robust induction of
chromatin remodeling occurs at a genome-wide level after
muscle trauma, and cis-regulatory elements such as pro-
moters were largely invariant when compared with regions
demarcated by enhancer marks (H3K4me1, H3K27ac).
Immediately after injury, the enriched enhancer regions
were associated with canonical mediators of early stress,
immunity, and growth factor responses, which was consis-
tent with the upregulation of cytokines and TFs such as
AP-1 (Fos/Jun), SRF, NF-kb, Egr, and Stats. The detection of
these transcripts and enriched enhancer sites was expected
since an appropriate inflammatory response is essential
for functional recovery after muscle injury. A significant
fraction of the enriched chromatin sites correlated with
transcriptional dynamics and was most likely attribut-
able to infiltrating monocytes that secrete and respond to
cytokines and chemokines. These early immune-related
changes were serially followed by changes in expression
and chromatin remodeling of genes associated with
anti-inflammatory macrophages (Arnold et al., 2007) and
activation and proliferation of SCs. During this period, up-
regulation of Smads and Tgf-b signaling was observed along
with increases in expression of TFs such as Tead4 (Benhad-
dou et al., 2012), Runx1 (Umansky et al., 2015), and MyoD
(Mullen et al., 2011). Smads have been shown to interact
with chromatin remodeling complexes such as histone ace-
tyltransferases p300 and CBP to induce H3K27 acetylation
(Pouponnot et al., 1998), which was consistent with the
observation that the highest number of sites that acquired
H3K27ac was in the middle time period. In addition,MyoD
has been shown to associate with p300 and p300/CBP on
E-box motifs of target genes (Puri et al., 1997), and interac-
tions between Smads and Tgf-b signaling have been shown
to alter myogenic differentiation kinetics, suggesting a
cooperative interaction between these different TFs and
chromatin remodeling complexes during this phase of
the injury response. Integrating these results reveals a tran-
sient shift in the balance of pro- and anti-inflammatory
cytokine programs (high expression of Il-6 and low expres-
sion of Tgf-b in the early period to low Il-6 expression and
high expression of Tgf-b in the middle period), which has
previously been shown to promote the recruitment and dif-
ferentiation of different types of cells that potentiate mus-
cle repair (neutrophils, M1macrophages, TH17 cells for the
early period, and M2 macrophages and Treg cells for the
middle period), influences chromatin state and expression
programs associated with proliferation and restraint of
myogenic differentiation (Dionyssiou et al., 2013).
IGF andPI3K signaling in regeneratingmusclewas tightly
regulated across multiple levels and temporally, especially
during the transition between myoblast proliferation anddifferentiation. In the early period, IGF1 was upregulated
and quickly followed by increases in expression and chro-
matin remodeling of myogenic negative regulators (Mg53,
Hdacs, Xbp1, Usf1) that alter how myogenic regulatory fac-
tors bind to lineage-specific genes. Starting at 72 hr, IGF1
and negative regulators began to decrease in expression
while positive differentiation genes increased in expres-
sion,which is consistentwith previous observations (Braun
and Gautel, 2011; Buckingham and Rigby, 2014; Pelosi
et al., 2007; Schiaffino and Mammucari, 2011; Matheny
and Adamo, 2010). This switch is consistent with the view
that miRs 206, 29, and 1a bind to Hdacs that reduce the
binding affinity of MyoD and Mef2, permitting these TFs
to initiatemyogenic regeneration.Given that IGF-activated
Akt1 modulates p300 to associate with MyoD (Serra et al.,
2007), it is intriguing to hypothesize how other parallel
regulatory schemas of this signaling pathway alter funda-
mental changes in TF binding and chromatin states that
drive muscle regeneration after severe trauma. Collec-
tively, these experiments imply that muscle repair and
regenerationuses different sets of transcriptional programs,
ncRNAs, and combinations of TFs as well as chromatin re-
modeling factors to precisely execute stage-specific gene
expression programs.We envision that a wider combinato-
rial interrogation of such a dataset can represent a valuable
resource to extend the networks acting in such a complex
microenvironment like the cis-regulatorymodules engaged
by TFs, miRNAs, and lncRNAs.EXPERIMENTAL PROCEDURES
Animals and Traumatic Injury Model
Mice were cared for in accordance with the Guide for the Care and
Use of Laboratory Animals in a facility accredited by the Associa-
tion for the Assessment and Accreditation of Laboratory Animal
Care (AAALAC).
Male C57BL/6J mice (10 weeks of age, 24–27 g) were obtained
from The Jackson Laboratory. Prior to administration of the freeze
injury, mice were anesthetized, and the TA muscle was exposed
via a small incision. Freeze injury was administered to the left hin-
dlimb by applying a 6-mm diameter steel probe (cooled to 70C)
to the belly of the TA muscle (directly below incision site) for 10 s.
Following injury, the skin incision was closed using absorbable
sutures (Ethicon). Five mice were euthanized at each time point
post injury (3, 10, 24, 48, 72, 168, 336, 504, and 672 hr) via CO2
inhalation (2 L/min), thoracotomy, and exsanguination. TA mus-
cles were removed from the injured and contralateral limb and
weighed, and approximately half of the tissue was processed
further (area delineated by the injury).Chromatin Isolation and Sequencing Library
Preparation
Each frozen tissue was thawed for at least 30 min and homoge-
nized (Tissue Ruptor, Qiagen), and the cells lysed for at leastStem Cell Reports j Vol. 7 j 983–997 j November 8, 2016 993
10 min. Next, nuclei were isolated, resuspended, and lysed for at
least 10 min. The chromatin was then sheared using a Branson
sonifier into fragments of size range 150–700 bp. The sheared chro-
matin was then incubated overnight at 4C with validated anti-
bodies (Modified Histone Peptide Array, Active Motif) H3K4me3
(Millipore catalog #07-743), H3K27ac (Active Motif #39133), and
H3K4me1 (Abcam #ab8895) using constant agitation, and co-
immunoprecipitated using a mixture of Protein A and Protein G
Dynabeads (Life Technologies) for 2 hr at 4C with constant agita-
tion. The immunoprecipitated chromatin was then washed, the
crosslinks were reversed and treated with Proteinase K, and DNA
was purified. Approximately 10 ng of isolated DNA was end-
repaired (End-It DNA End-Repair Kit, Epicenter), extended, and
A-tailed (New England Biolabs), and ligated to sequencing adaptor
oligos (Illumina). The adaptor-modified library was then amplified
by PFU Ultra II Hotstart Master Mix (Agilent) and size-selected to a
range of 300–600 bpprior to sequencing. Libraries were pooled and
sequenced using an Illumina Genome Analyzer IIx using 44-bp
single end reads to achieve approximately 20 M aligned reads per
sample.
mRNAand Small RNA Sequencing Library Preparation
and qPCR
The extracted tissue was thawed and then homogenized for 30 s
(Tissue Ruptor, Qiagen), and total RNA was isolated using the
miRNeasy Mini Kit (Qiagen) as per the manufacturer’s instructions.
Total RNA from sorted SCswere extractedusing themiRNeasyMicro
Kit (Qiagen), and RNA concentration and integrity for both types of
samples (tissues and sorted cells) were measured with a Nanodrop
spectrophotometer (Nanodrop 2000c) and Bioanalyzer (Agilent
2100). One microgram of isolated total RNA from tissues was used
toproduce strand-specificcDNAlibrariesusing theTruseq (Illumina)
protocol, as per the manufacturer’s instructions. Ten nanograms of
isolated total RNA from SCs was used to produce cDNA libraries
using the SmartSeq4 protocol (Clontech), as per the manufacturer’s
instructions. Individual libraries from tissues were pooled and
sequenced using 12 lanes of 76-bp paired-end reads on an Illumina
Genome Analyzer IIx to an average depth of 50 M reads per library.
Individual libraries for the sorted SCswere pooledand sequencedus-
ing 76-bp paired-end reads on an Illumina NextSeq to an average
depth of 50 M reads per library.
For the production of miRNA-seq libraries 500 ng of total RNA
from the tissues and 100 ng of total RNA from the sorted cells
was used, and libraries were prepared according to the specifi-
cations of the Truseq small-RNA kit (Illumina). Each library was
then pooled and sequenced on a MiSeq single-ended 35-bp run
(Illumina) to >1 M reads per library.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and seven figures and can be foundwith this article on-
line at http://dx.doi.org/10.1016/j.stemcr.2016.09.009.
ACKNOWLEDGMENTS
The authors thank Chet Beal for assistance with artwork, Sara
Chauvin, Patrick Boyle, Fontina Kelley, and the Broad Institute994 Stem Cell Reports j Vol. 7 j 983–997 j November 8, 2016Genomics Platform for sequencing and technical assistance, Tara
Boettcher for assistance with ChIP and sequencing library prepara-
tion, Mary Abdalla, Christina Zook, and Alyssa Geddis for tech-
nical assistance with PCR, andDarrell O. Ricke andMichael J. Ziller
for insightful discussions. This material is based upon work sup-
ported under Air Force Contract No. FA8721-05-C-0002 and/or
FA8702-15-D-0001. Opinions, interpretations, recommendations,
and conclusions are those of the authors and are not necessarily
endorsed by the United States Government. Any opinions, find-
ings, conclusions, or recommendations expressed in this material
are those of the author(s) and do not necessarily reflect the views
of the U.S. Air Force. C.C. was supported by an appointment to
the postgraduate research participation program at the US Army
Research Institute of Environmental Medicine, administered by
the Oak Ridge Institute for Science and Education through an
interagency agreement between the US Department of Energy
and the US Army Medical Research and Materiel Command. The
views, opinions, and/or findings of this report are those of the au-
thors and should not be construed as an official US Department of
the Army position, policy, or decision unless so designated by
other official documentation.
Received: April 28, 2016
Revised: September 16, 2016
Accepted: September 20, 2016
Published: October 20, 2016REFERENCES
Acosta-Alvear, D., Zhou, Y., Blais, A., Tsikitis, M., Lents, N.H., Arias,
C., Lennon, C.J., Kluger, Y., and Dynlacht, B.D. (2007). XBP1 con-
trols diverse cell type- and condition-specific transcriptional regu-
latory networks. Mol. Cell 27, 53–66.
Aguilar, C.A., Shcherbina, A., Ricke, D.O., Pop, R., Carrigan, C.T.,
Gifford, C.A., Urso, M.L., Kottke, M.A., and Meissner, A. (2015).
In vivo monitoring of transcriptional dynamics after lower-limb
muscle injury enables quantitative classification of healing. Sci.
Rep. 5, 13885.
Almada, A.E., and Wagers, A.J. (2016). Molecular circuitry of stem
cell fate in skeletal muscle regeneration, ageing and disease. Nat.
Rev. Mol. Cell Biol. 17, 267–279.
Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N.,
Plonquet, A., Gherardi, R.K., and Chazaud, B. (2007). Inflamma-
tory monocytes recruited after skeletal muscle injury switch into
anti-inflammatory macrophages to support myogenesis. J. Exp.
Med. 204, 1057–1069.
Arnold, C.P., Tan, R., Zhou, B., Yue, S.B., Schaffert, S., Biggs, J.R.,
Doyonnas, R., Lo, M.C., Perry, J.M., Renault, V.M., et al. (2011).
MicroRNA programs in normal and aberrant stem and progenitor
cells. Genome Res. 21, 798–810.
Asp, P., Blum, R., Vethantham, V., Parisi, F., Micsinai, M., Cheng, J.,
Bowman, C., Kluger, Y., and Dynlacht, B.D. (2011). Genome-wide
remodeling of the epigenetic landscape during myogenic differen-
tiation. Proc. Natl. Acad. Sci. USA 108, E149–E158.
Aurora, A.B., and Olson, E.N. (2014). Immunemodulation of stem
cells and regeneration. Cell Stem Cell 15, 14–25.
Benhaddou, A., Keime, C., Ye, T., Morlon, A., Michel, I., Jost, B.,
Mengus, G., and Davidson, I. (2012). Transcription factor TEAD4
regulates expression of myogenin and the unfolded protein
response genes during C2C12 cell differentiation. Cell Death
Differ. 19, 220–231.
Bentzinger, C.F., Wang, Y.X., Dumont, N.A., and Rudnicki, M.A.
(2013). Cellular dynamics in the muscle satellite cell niche.
EMBO Rep. 14, 1062–1072.
Betel, D., Koppal, A., Agius, P., Sander, C., and Leslie, C. (2010).
Comprehensivemodeling of microRNA targets predicts functional
non-conserved and non-canonical sites. Genome Biol. 11, R90.
Blais, A., Tsikitis, M., Acosta-Alvear, D., Sharan, R., Kluger, Y., and
Dynlacht, B.D. (2005). An initial blueprint for myogenic differen-
tiation. Genes Dev. 19, 553–569.
Blum, R., Vethanthum, V., Bowman, C., Rudnicki, M., and Dyn-
lacht, B.D. (2012). Genome-wide identification of enhancers in
skeletal muscle: the role of MyoD1. Genes Dev. 26, 2763–2779.
Brancaccio, A., and Palacios, D. (2015). Chromatin signaling in
muscle stem cells: interpreting the regenerative microenviron-
ment. Front. Aging Neurosci. 7, 1–17.
Braun, T., and Gautel, M. (2011). Transcriptional mechanisms
regulating skeletal muscle differentiation, growth and homeosta-
sis. Nat. Rev. Mol. Cell Biol. 12, 349–361.
Buckingham, M., and Rigby, P.W.J. (2014). Gene regulatory net-
works and transcriptional mechanisms that control myogenesis.
Dev. Cell 28, 225–238.
Burzyn, D., Kuswanto,W., Kolodin, D., Shadrach, J.L., Cerletti, M.,
Jang, Y., Sefik, E., Tan, T.G.,Wagers, A.J., Benoist, C., andMathis, D.
(2013). A special population of regulatory T cells potentiates mus-
cle repair. Cell 155, 1282–1295.
Cacchiarelli, D., Martone, J., Girardi, E., Cesana, M., Incitti, T.,
Morlando, M., Nicoletti, C., Santini, T., Sthandier, O., Barberi, L.,
et al. (2010). MicroRNAs involved in molecular circuitries relevant
for the Duchennemuscular dystrophy pathogenesis are controlled
by the dystrophin/nNOS pathway. Cell Metab. 12, 341–351.
Cacchiarelli, D., Incitti, T., Martone, J., Cesana, M., Cazzella, V.,
Santini, T., Sthandier, O., and Bozzoni, I. (2011).miR-31modulates
dystrophin expression: new implications for Duchenne muscular
dystrophy therapy. EMBO Rep. 12, 136–141.
Calve, S., Odelberg, S.J., and Simon, H.G. (2010). A transitional
extracellular matrix instructs cell behavior during muscle regener-
ation. Dev. Biol. 344, 259–271.
Cao, Y., Yao, Z., Sarkar, D., Lawrence, M., Sanchez, G.J., Parker,
M.H., MacQuarrie, K.L., Davison, J., Morgan, M.T., Ruzzo, W.L.,
et al. (2010). Genome-wide MyoD binding in skeletal muscle
cells: a potential for broad cellular reprogramming. Dev. Cell 18,
662–674.
Cesana, M., Cacchiarelli, D., Legnini, I., Santini, T., Sthandier, O.,
Chinappi, M., Tramontano, A., and Bozzoni, I. (2011). A long non-
coding RNA controls muscle differentiation by functioning as a
competing endogenous RNA. Cell 147, 358–369.
Chen, J.F., Mandel, E.M., Thomson, J.M., Wu, Q., Callis, T.E.,
Hammond, S.M., Conlon, F.L., and Wang, D.Z. (2005). The role
of microRNA-1 andmicroRNA-133 in skeletal muscle proliferation
and differentiation. Nat. Genet. 38, 228–233.Creyghton, M.P., Cheng, A.W., Welstead, G.G., Kooistra, T., Carey,
B.W., Steine, E.J., Hanna, J., Lodato, M.A., Frampton, G.M., Sharp,
P.A., et al. (2010). Histone H3K27ac separates active from poised
enhancers and predicts developmental state. Proc. Natl. Acad.
Sci. USA 107, 21931–21936.
Dey, B.K., Pfeifer, K., and Dutta, A. (2014). The H19 long noncod-
ing RNA gives rise to microRNAs miR-675-3p and miR-675-5p to
promote skeletal muscle differentiation and regeneration. Genes
Dev. 28, 491–501.
Dionyssiou, M.G., Salma, J., Bevzyuk, M., Zakharyan, L., and
McDermott, J.C. (2013). Kruppel-like factor 6 (KLF6) promotes
cell proliferation in skeletal myoblasts in response to TGF-b/
Smad3 signaling. Skeletal Muscle 3, 7.
Eisenberg, I., Eran, A., Nishino, I., Moggio, M., Lamperti, C.,
Amato, A.A., Lidov, H.G., Kang, P.B., North, K.N., Mitrani-Rose-
nbaum, S., et al. (2007). Distinctive patterns of microRNA expres-
sion in primary muscular disorders. Proc. Natl. Acad. Sci. USA
104, 17016–17021.
Ernst, J., Kheradpour, P., Mikkelsen, T.S., Shoresh, N., Ward, L.D.,
Epstein, C.B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al.
(2011). Mapping and analysis of chromatin state dynamics in
nine human cell types. Nature 473, 43–49.
Faralli, H., Wang, C., Nakka, K., Benyoucef, A., Sebastian, S.,
Zhuang, L., Chu, A., Palii, C.G., Liu, C., Camellato, B., et al.
(2016). UTX demethylase activity is required for satellite cell-medi-
ated muscle regeneration. J. Clin. Invest. 126, 1555–1565.
Farina, N.H., Hausberg, M., Betta, N.D., Pulliam, C., Srivastava, D.,
Cornelison, D., and Olwin, B.B. (2012). A role for RNA post-tran-
scriptional regulation in satellite cell activation. Skeletal Muscle
2, 21.
Garber, M., Yosef, N., Goren, A., Raychowdhury, R., Thielke, A.,
Guttman, M., Robinson, J., Minie, B., Chevrier, N., Itzhaki, Z.,
et al. (2012). A high-throughput chromatin immunoprecipitation
approach reveals principles of dynamic gene regulation in mam-
mals. Mol. Cell 47, 1–13.
Giordani, L., and Puri, P.L. (2013). Epigenetic control of skeletal
muscle regeneration: integrating genetic determinants and envi-
ronmental changes. FEBS J. 280, 4014–4025.
Gong, C., Li, Z., Ramanujan, K., Clay, I., Zhang, Y., Lemire-Brachat,
S., and Glass, D.J. (2015). A long noncoding RNA, LincMyoD, reg-
ulates skeletal muscle differentiation by blocking IMP2-mediated
mRNA translation. Dev. Cell 34, 181–191.
Heredia, J.E., Mukundan, L., Chen, F.M., Mueller, A.A., Deo, R.C.,
Locksley, R.M., Rando, T.A., and Chawla, A. (2013). Type 2 innate
signals stimulate fibro/adipogenic progenitors to facilitate muscle
regeneration. Cell 153, 376–388.
Kim, H.K., Lee, Y.S., Sivaprasad, U., Malhotra, A., and Dutta, A.
(2006). Muscle specific microRNA miR-206 promotes muscle dif-
ferentiation. J. Cell Biol. 174, 677–687.
Kuang, S., Gillespie, M.A., and Rudnicki, M.A. (2008). Niche regu-
lation of muscle satellite cell self-renewal and differentiation. Cell
Stem Cell 2, 22–31.
Kuwahara, K., Barrientos, T., Pipes, G.C.T., Li, S., and Olson, E.N.
(2005). Muscle-specific signaling mechanism that links actin dy-
namics to serum response factor. Mol. Cell. Biol. 25, 3173–3181.Stem Cell Reports j Vol. 7 j 983–997 j November 8, 2016 995
Liu, Q., Fu, H., Sun, F., Zhang, H., Tie, Y., Zhu, J., Xing, R., Sun, Z.,
and Zheng, X. (2008). miR-16 family induces cell cycle arrest by
regulating multiple cell cycle genes. Nucleic Acids Res. 36, 5391–
5404.
Liu, N., Williams, A.H., Maxeiner, J.M., Bezprozvannaya, S., Shel-
ton, J.M., Richardson, J.A., Bassel-Duby, R., and Olson, E.N.
(2012). microRNA-206 promotes skeletal muscle regeneration
and delays progression of Duchenne muscular dystrophy in
mice. J. Clin. Invest. 122, 2054–2065.
Liu, L., Cheung, T.H., Charville, G.W., Hurgo, B.M., Leavitt, T.,
Shih, J., Brunet, A., and Rando, T.A. (2013). Chromatin modifica-
tions as determinants of muscle stem cell quiescence and chrono-
logical aging. Cell Rep. 4, 189–204.
Liu, N., Nelson, B.R., Bezprozvannaya, S., Shelton, J.M., Richard-
son, J.A., Bassel-Duby, R., and Olson, E.N. (2014). Requirement
of MEF2A, C, and D for skeletal muscle regeneration. Proc. Natl.
Acad. Sci. USA 111, 4109–4114.
Liu, L., Cheung, T.H., Charville, G.W., and Rando, T.A. (2015).
Isolation of skeletal muscle stem cells by fluorescence-activated
cell sorting. Nat. Protoc. 10, 1612–1624.
Lu,W., You, R., Yuan, X., Yang, T., Samuel, E.L., Marcano, D.C., Sik-
kema, W.K., Tour, J.M., Rodriguez, A., Kheradmand, F., and Corry,
D.B. (2015). The microRNA miR-22 inhibits the histone deacety-
lase HDAC4 to promote TH17 cell-dependent emphysema. Nat.
Immuno. 16, 1185–1194.
Matheny, R.W., and Adamo, M.L. (2010). PI3K p110 alpha and
p110 beta have differential effects on Akt activation and protec-
tion against oxidative stress-induced apoptosis in myoblasts. Cell
Death Differ. 17, 677–688.
Matheny, R.W., Lynch, C.M., and Leandry, L.A. (2012).
Enhanced Akt phosphorylation and myogenic differentiation in
PI3K p110beta-deficient myoblasts is mediated by PI3K p110alpha
and mTORC2. Growth Factors 30, 367–384.
Matheny, R.W., Riddle-Kottke, M.A., Leandry, L.A., Lynch, C.M.,
Abdalla, M.N., Geddis, A.V., Piper, D.R., and Zhao, J.J. (2015).
Role of phosphoinositide 3-OH kinase p110beta in skeletal myo-
genesis. Mol. Cell. Biol. 35, 1182–1196.
Molkentin, J.D., Black, B.L., Martin, J.F., and Olson, E.N. (1995).
Cooperative activation of muscle gene expression by MEF2 and
myogenic BHLH proteins. Cell 83, 2–14.
Mousavi, K., Zare, H., Dell’orso, S., Grontved, L., Gutierrez-Cruz,
G., Derfoul, A., Hager, G.L., and Sartorelli, V. (2013). eRNAs pro-
moted transcription by establishing chromatin accessibility at
defined genomic loci. Mol. Cell 51, 606–617.
Mullen, A.C., Orlando, D.A., Newman, J.J., Love´n, J., Kumar, R.M.,
Bilodeau, S., Reddy, J., Guenther, M.G., DeKoter, R.P., and Young,
R.A. (2011). Master transcription factors determine cell-type-spe-
cific responses to TGFb signaling. Cell 147, 565–576.
Neguembor, M.V., Jothi, M., and Gabellini, D. (2014). Long non-
coding RNAs, emerging players in muscle differentiation and dis-
ease. Skeletal Muscle 4, 1–12.
Ostuni, R., Piccolo, V., Barozzi, I., Polletti, S., Termanini, A., Boni-
facio, S., Curina, A., Prosperini, E., Ghisletti, S., and Natoli, G.
(2013). Latent enhancers activated by stimulation in differentiated
cells. Cell 152, 157–171.996 Stem Cell Reports j Vol. 7 j 983–997 j November 8, 2016Palacios, D., and Puri, P.L. (2006). The epigenetic network
regulating muscle development and regeneration. J. Cell Physiol.
207, 1–11.
Pallafacchina, G., Francois, S., Regnault, B., Czarny, B., Drive, V.,
Cumano, A., Montarras, D., and Buckingham, M. (2010). An adult
tissue-specific stem cell in its niche: a agene profiling analysis of
in vivo quiescent and activated muscle satellite cells. Stem Cell
Res. 4, 77–91.
Pelosi, L., Giacinti, C., Nardis, C., Borsellino, G., Rizzuto, E., Nico-
letti, C., Wannenes, F., Battistini, L., Rosenthal, N., Molinaro, M.,
and Musaro`, A. (2007). Local expression of IGF-1 accelerates mus-
cle regeneration by rapidly modulating inflammatory cytokines
and chemokines. FASEB J. 21, 1393–1402.
Pouponnot, C., Jayaraman, L., and Massague, J. (1998). Physical
and functional interaction of SMADs and p300/CBP. J. Biol.
Chem. 273, 22865–22868.
Puri, P.L., Avantaggiati, M.L., Balsano, C., Sang, N., Graessmann,
A., Giordano, A., and Levrero, M. (1997). p300 is required for
MyoD-dependent cell cycle arrest and muscle-specific gene tran-
scription. EMBO J. 16, 369–383.
Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S.A., Flynn, R.A.,
and Wysocka, J. (2011). A unique chromatin signature uncovers
early developmental enhancers in humans. Nature 470, 279–283.
Rodgers, J.T., King, K.Y., Brett, J.O., Cromie, M.J., Charville, G.W.,
Maguire, K.K., Brunson, C., Mastey, N., Liu, L., Tsai, C.R., et al.
(2014). mTORC1 controls the adaptive transition of quiescent
stem cells from G0 to GAlert. Nature 510, 393–396.
Scharner, J., and Zammit, P.S. (2011). Themuscle satellite cell at 50:
the formative years. Skeletal Muscle 1, 28.
Schiaffino, S., and Mammucari, C. (2011). Regulation of skeletal
muscle growth by the IGF1-Akt/PKB pathway: insights from
genetic models. Skeletal Muscle 1, 1–14.
Serra, C., Palacios, D., Mozzetta, C., Forcales, S.V., Morantte, I.,
Ripani, M., Jones, D.R., Du, K., Jhala, U.S., Simone, C., and Puri,
P.L. (2007). Functional interdependence at the chromatin level be-
tween theMKK6/p38 and IGF1/PI3K/AKTpathways duringmuscle
differentiation. Mol. Cell 28, 200–213.
Soleimani, V.D., Yin, H., Jahani-Asl, A., Ming, H., Kockx, C.E.M.,
van Ijcken, W.F.J., Grosveld, F., and Rudnicki, M.A. (2012). Snail
regulates Myod binding-site occupancy to direct enhancer switch-
ing and differentiation-specific transcription in myogenesis. Mol.
Cell 47, 457–468.
The Mouse ENCODE Consortium (2014). A comparative ency-
clopedia of DNA elements in the mouse genome. Nature 515,
355–364.
Tidball, J.G. (2005). Inflammatory processes in muscle injury and
repair. J. Physiol. Regul. Integr. Comp. Physiol. 288, R345–R353.
Toth, K.G.,McKay, B.R., De Lisio,M., Little, J.P., Tarnopolsky,M.A.,
and Parise, G. (2011). IL-6 induced Stat3 signalling is associated
with the proliferation of human muscle satellite cells following
acute muscle damage. PLoS One 6, e17392.
Umansky, K.B., Gruenbaum-Cohen, Y., Tsoory, M., Feldmesser, E.,
Goldenberg, D., Brenner, O., and Groner, Y. (2015). Runx1 tran-
scription factor is required for myoblast proliferation during mus-
cle regeneration. PLoS Genet. 11, e1005457.
Warren, G.L., Summan, M., Gao, X., Chapman, R., Hulderman, T.,
and Simeonova, P.P. (2007). Mechanisms of skeletal muscle injury
and repair revealed by gene expression studies in mouse models.
J. Physiol. 582, 825–841.
Yi, J.S., Park, J.S., Ham, Y.M., Nguyen, N., Lee, N.R., Hong, J., Kim,
B.W., Lee, H., Lee, C.S., Jeong, B.C., et al. (2013). MG53-induced
IRS-1 ubiquitination negatively regulates skeletal myogenesis and
insulin signalling. Nat. Commun 4, 2354.Zangrado, J., Zhang, L., Vausort, M., Maskali, F., Marie, P.Y., Wag-
ner, D.R., and Devaux, Y. (2014). Identification of candidate long
non-coding RNAs in response to myocardial infarction. BMC
Genomics 15, 460.
Zhang, Y., Yang, P., Sun, T., Li, D., Xu, X., Rui, Y., Li, C., Chong, M.,
Ibrahim,T.,Mercatali, L., et al. (2013).miR-126andmiR-126* repress
recruitment of mesenchymal stem cells and inflammatory mono-
cytes to inhibit breast cancermetastasis. Nat. Cell Biol. 15, 284–294.Stem Cell Reports j Vol. 7 j 983–997 j November 8, 2016 997
